Literature DB >> 18281653

Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions?

Pamela J Goodwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18281653     DOI： 10.1200/JCO.2007.14.7132

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  26 in total

1.  Insulin resistance and chronic liver disease.

Authors:  Takumi Kawaguchi; Eitaro Taniguchi; Minoru Itou; Masahiro Sakata; Shuji Sumie; Michio Sata
Journal:  World J Hepatol       Date:  2011-05-27

Review 2.  The key role of growth hormone-insulin-IGF-1 signaling in aging and cancer.

Authors:  Vladimir N Anisimov; Andrzej Bartke
Journal:  Crit Rev Oncol Hematol       Date:  2013-02-21       Impact factor: 6.312

Review 3.  Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

Authors:  J A Johnson; B Carstensen; D Witte; S L Bowker; L Lipscombe; A G Renehan
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

Review 4.  Metformin: a therapeutic opportunity in breast cancer.

Authors:  Ana M Gonzalez-Angulo; Funda Meric-Bernstam
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

5.  Should diabetic women with breast cancer have their own intervention studies?

Authors:  David A Potter; Douglas Yee; Zhijun Guo; Mariangellys Rodriguez
Journal:  Endocr Relat Cancer       Date:  2012-02-13       Impact factor: 5.678

Review 6.  BET proteins in abnormal metabolism, inflammation, and the breast cancer microenvironment.

Authors:  Guillaume P Andrieu; Jordan S Shafran; Jude T Deeney; Kishan R Bharadwaj; Annapoorni Rangarajan; Gerald V Denis
Journal:  J Leukoc Biol       Date:  2018-03-01       Impact factor: 4.962

Review 7.  Do metformin a real anticarcinogen? A critical reappraisal of experimental data.

Authors:  Vladimir N Anisimov
Journal:  Ann Transl Med       Date:  2014-06

Review 8.  Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.

Authors:  Iván P Uray; Powel H Brown
Journal:  Recent Results Cancer Res       Date:  2011

9.  Long-term metformin use is associated with decreased risk of breast cancer.

Authors:  Michael Bodmer; Christian Meier; Stephan Krähenbühl; Susan S Jick; Christoph R Meier
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

10.  Glucose promotes breast cancer aggression and reduces metformin efficacy.

Authors:  Reema Wahdan-Alaswad; Zeying Fan; Susan M Edgerton; Bolin Liu; Xin-Sheng Deng; Sigrid Salling Arnadottir; Jennifer K Richer; Steven M Anderson; Ann D Thor
Journal:  Cell Cycle       Date:  2013-10-03       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.